Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Asset Writedowns and Impairment (2018 - 2020)

Catheter Precision (VTAK) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $155000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Asset Writedowns and Impairment rose 811.76% to $155000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $180000.0, a 36.4% decrease, with the full-year FY2022 number at $21000.0, down 55.32% from a year prior.
  • Asset Writedowns and Impairment was $155000.0 for Q4 2020 at Catheter Precision, up from $10000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $242000.0 in Q2 2019 to a low of $10000.0 in Q2 2020.
  • A 3-year average of $78714.3 and a median of $24000.0 in 2019 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 811.76% in 2020; the steepest drop was 95.87% in 2020.
  • Catheter Precision's Asset Writedowns and Impairment stood at $88000.0 in 2018, then crashed by 80.68% to $17000.0 in 2019, then surged by 811.76% to $155000.0 in 2020.
  • Per Business Quant, the three most recent readings for VTAK's Asset Writedowns and Impairment are $155000.0 (Q4 2020), $10000.0 (Q2 2020), and $15000.0 (Q1 2020).